US Stock MarketDetailed Quotes
BLAC Bellevue Life Sciences Acquisition
- 10.710
- 0.0000.00%
Trading May 3 11:20 ET
60.22MMarket Cap148.75P/E (TTM)
10.710High10.710Low18.00KVolume10.710Open10.710Pre Close192.78KTurnover0.64%Turnover Ratio148.75P/E (Static)5.62MShares11.16052wk High1.85P/B30.07MFloat Cap10.15052wk Low--Dividend TTM2.81MShs Float11.160Historical High--Div YieldTTM0.00%Amplitude10.070Historical Low10.710Avg Price1Lot Size
About Bellevue Life Sciences Acquisition Company
Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Company Profile
SymbolBLAC
Company NameBellevue Life Sciences Acquisition
Listing DateFeb 10, 2023
Founded2020
CEOMr. Kuk Hyoun Hwang
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10900 NE 4th Street,Suite 2300
CityBellevue
ProvinceWashington
CountryUnited States of America
Zip Code98004
Phone1-425-635-7700
Websitehttps://www.bellevuespac.com
Company Executives
- Name
- Position
- Salary
- Kuk Hyoun Hwang
- Chief Executive Officer and Director
- --
- David Jin Yoo
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven G. Reed
- Chairman of the Board
- --
- Jun Chul Whang
- Director
- --
- Jin Whan Park
- Independent Director
- --
- Dr. Rad Roberts
- Independent Director
- --
- Dr. In Chul Chung
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg